Patents by Inventor Matthew P. Vincent

Matthew P. Vincent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158756
    Abstract: The present invention relates to a culture media system that is useful for the isolation and epigenetically stable propagation of normal stem cells in culture, wherein the stem cells are derived from stratified epithelial tissues and cancer stem cells from epithelial cancers. In certain embodiments, the culture system is a feeder-free system.
    Type: Application
    Filed: October 9, 2020
    Publication date: May 16, 2024
    Applicant: University of Houston System
    Inventors: Frank McKEON, Wa XIAN, Matthew P. VINCENT, Jingzhong XIE, Wei RAO
  • Publication number: 20230390409
    Abstract: Disclosed herein are therapeutic conjugates having an extended circulating serum half-life. The therapeutic conjugates comprise a therapeutic moiety linked to a half-life extension moiety via a fibroblast activation protein, alpha (FAP?)-cleavable linker. Methods of using the therapeutic conjugates are also provided.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 7, 2023
    Applicants: Avacta Life Sciences Limited, Trustees of Tufts College
    Inventors: Amrik Basran, Matthew P. Vincent, Emma Jenkins, Estelle Adam, William Bachovchin
  • Publication number: 20230381330
    Abstract: Disclosed herein are therapeutic conjugates having an extended circulating serum half-life. The therapeutic conjugates comprise a drug moiety linked to a half-life extension moiety via an enzyme-cleavable linker. Methods of using the therapeutic conjugates are also provided.
    Type: Application
    Filed: October 29, 2021
    Publication date: November 30, 2023
    Applicants: Avacta Life Sciences Limited, Trustees of Tufts College
    Inventors: Amrik Basran, Matthew P. Vincent, Emma Jenkins, Estelle Adam, William Bachovchin
  • Publication number: 20230357714
    Abstract: The present invention relates to a culture media system that useful for the isolation and epigenetically stable propagation of normal stem cells in culture which are derived from columnar epithelial tissues and cancer stem cells from epithelial cancers. In certain embodiments, the culture system is a feeder-free system.
    Type: Application
    Filed: June 19, 2023
    Publication date: November 9, 2023
    Applicant: UNIVERSITY OF HOUSTON SYSTEM
    Inventors: Wa XIAN, Frank McKEON, Matthew P. VINCENT
  • Publication number: 20230272011
    Abstract: Provided herein, in some embodiments, are recombinantly engineered variant of stefin polypeptides (AFFIMER® polypeptides) that binds to human serum albumin and extends the half-life of the polypeptides. Also provided herein, in some embodiments, are composition containing the polypeptides, methods of using the polypeptides, and methods of producing the polypeptides.
    Type: Application
    Filed: July 30, 2021
    Publication date: August 31, 2023
    Applicant: Avacta Life Sciences Limited
    Inventors: Emma Jenkins, Estelle Adam, Emma Stanley, Amrik Basran, Matthew P. Vincent, Bruno Gomes
  • Publication number: 20230272081
    Abstract: Provided herein, in some embodiments, are fusion proteins comprising recombinantly engineered variant of stefin polypeptide (an AFFIMER® polypeptide) that binds to PD-L1 and a polypeptide that binds to human serum albumin (HSA). Also provided herein, in some embodiments, are compositions containing the fusion proteins, methods of using the fusion proteins, and methods of producing the fusion proteins.
    Type: Application
    Filed: July 30, 2021
    Publication date: August 31, 2023
    Applicant: Avacta Life Sciences Limited
    Inventors: Emma Jenkins, Estelle Adam, Emma Stanley, Amrik Basran, Matthew P. Vincent
  • Patent number: 11725185
    Abstract: The present invention relates to a culture media system that is useful for the isolation and epigenetically stable propagation of normal stem cells in culture which are derived from columnar epithelial tissues and cancer stem cells from epithelial cancers. In certain embodiments, the culture system is a feeder-free system.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: August 15, 2023
    Assignee: University of Houston System
    Inventors: Wa Xian, Frank McKeon, Matthew P. Vincent
  • Publication number: 20210062145
    Abstract: The present invention relates to a culture media system that is useful for the isolation and epigenetically stable propagation of normal stem cells in culture which are derived from columnar epithelial tissues and cancer stem cells from epithelial cancers. In certain embodiments, the culture system is a feeder-free system.
    Type: Application
    Filed: December 28, 2018
    Publication date: March 4, 2021
    Applicants: University of Houston System, Tract Pharmaceuticals, Inc.
    Inventors: Wa XIAN, Frank McKEON, Marcin DULEBA, Matthew P. VINCENT
  • Publication number: 20100094722
    Abstract: Disclosed herein are methods and systems for establishing a network-based system for purchase and sale of at least one of an option contract and a futures contract to acquire a travel-related item. The contract may be exercisable upon occurrence of a contingency and tradable in an online marketplace. In some instances, the contract may be exercisable upon future existence of the travel-related item, occurrence of a weather condition, or the outcome of a contest, any of which may be uncertain at the time of the purchase and sale of the contract.
    Type: Application
    Filed: October 12, 2009
    Publication date: April 15, 2010
    Applicant: THE TICKET RESERVE, INC.
    Inventors: CHARLES H. CELLA, EDWARD J. KELLY, MATTHEW P. VINCENT
  • Patent number: 7660752
    Abstract: A system for allowing a remote user to purchase and trade, over a distributed computer network (e.g., the Internet), an option for a ticket and/or accommodations for a “contingent event,” i.e., an event which is certain to occur but for which the participants, content and/or location(s) are not predetermined. For instance, the subject system can be used to sell and trade options for the purchase of tickets to such contingent events such as playoff games on the basis of what teams qualify.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: February 9, 2010
    Assignee: The Ticket RESERVE, Inc.
    Inventors: Charles H. Cella, Edward J. Kelly, Matthew P. Vincent
  • Patent number: 7660751
    Abstract: A system for allowing a remote user to purchase and trade, over a distributed computer network (e.g., the Internet), an option for a ticket and/or accommodations for a “contingent event,” i.e., an event which is certain to occur but for which the participants, content and/or location(s) are not predetermined. For instance, the subject system can be used to sell and trade options for the purchase of tickets to such contingent events such as playoff games on the basis of what teams qualify.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: February 9, 2010
    Assignee: The Ticket RESERVE, Inc.
    Inventors: Charles H. Cella, Edward J. Kelly, Matthew P. Vincent
  • Patent number: 7610220
    Abstract: A system for allowing a remote user to purchase, over a distributed computer network (e.g., the Internet), an option for a ticket and/or accommodations for a “contingent event,”i.e., an event which is certain to occur but for which the participants, content and/or location(s) are not predetermined. For instance, the subject system can be used to sell options for the purchase of tickets to contingent events such as playoff games on the basis of what individuals qualify for the game.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: October 27, 2009
    Assignee: The Ticket RESERVE, Inc.
    Inventors: Charles H. Cella, Edward J. Kelly, Matthew P. Vincent
  • Patent number: 7610221
    Abstract: Methods and systems of establishing a network-based system for purchase and sale of at least one of an option contract and a futures contract to acquire an item or to attend an event, wherein the contract is exercisable upon the occurrence of a contingency. The contingency may relate to the presence of a particular team in a game and the location of the game. In some instances, the contingency may relate to the position of a participant in the event in the standings at a time proximate to the occurrence of the event.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: October 27, 2009
    Assignee: The Ticket RESERVE, Inc.
    Inventors: Charles H. Cella, Edward J. Kelly, Matthew P. Vincent
  • Patent number: 7363267
    Abstract: Disclosed herein is a system for allowing a remote user to purchase, over a distributed computer network (e.g., the Internet), an option for a ticket and/or accommodations for a “contingent event”, e.g., an event which is certain to occur but for which the participants, content and/or location(s) are not predetermined. For instance, the subject system can be used to sell options for the purchase of tickets to such contingent events such as playoff games on the basis of what teams qualify, or all-star game.
    Type: Grant
    Filed: June 5, 2000
    Date of Patent: April 22, 2008
    Assignee: The Ticket Reserve, Inc.
    Inventors: Matthew P. Vincent, Charles H. Cella, Edward J. Kelly